UPLYSO

Protalix signs supply deal with Brazilian government for Gaucher disease treatment
Yahoo/AP
Wed, 06/19/13 - 10:31 am
Protalix
Brazil
Gaucher disease
UPLYSO
Niche Opportunity May Be Slipping From Protalix's Grasp
Seeking Alpha
Tue, 03/1/11 - 10:31 am
Protalix BioTherapeutics
UPLYSO
Gaucher disease
Shire
Cerezyme
Genzyme
Vpriv
FDA Catalyst Trade: Protalix BioTherapeutics
Seeking Alpha
Wed, 02/2/11 - 12:02 pm
FDA
Protalix BioTherapeutics
Pfizer
UPLYSO
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Pfizer Acts on Growing Interest in Niche Drugs
Seeking Alpha
Fri, 09/3/10 - 08:06 am
Protalix BioTherapeutics
Pfizer
UPLYSO
M&A
tafamidis meglumine
FoldRx
Six Trades on FDA, Clinical Trial Binary Events
Seeking Alpha
Tue, 07/13/10 - 09:14 pm
BioSante
LibiGel
testosterone
EntreMed
ENMD-2076
cancer
Protalix BioTherapeutics
UPLYSO
ovarian cancer
Vivus
Qnexa
obesity
EMD 640744
cancer vaccines